Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2025-05-14 2025-05-14
Drug Identification Number 02239028 02239028
Brand name EVISTA EVISTA
Common or Proper name raloxifene hydrochloride tablet raloxifene hydrochloride tablet
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients RALOXIFENE HYDROCHLORIDE RALOXIFENE HYDROCHLORIDE
Strength(s) 60MG 60MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Carton containing 28 tablets in blister packaging Carton containing 28 tablets in blister packaging
ATC code G03XC G03XC
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2026-01-30 2026-01-30
Actual discontinuation date
Remaining supply date 2026-01-30 2026-01-30
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments